Prescription Drug Affordability Review Board

Colorado Prescription Drug Affordability Review Board & Advisory Council

To receive PDAB and PDAAC updates directly in your inbox, click the button below. To subscribe, you will need to enter your email and then choose Updates From Divisions > Division of Insurance > Division of Insurance Prescription Drug Affordability Board.

PDAB Overview

Colorado’s Prescription Drug Affordability Board (PDAB), established under Senate Bill 21-175, is a Type-1 Board within the Division of Insurance that will have the authority to review prescription drug costs and evaluate their impact on Coloradans. The Board may then recommend ways to address those costs and may set an upper payment limit for certain drugs. The Board has appointed a multi-stakeholder Advisory Council to provide input to the Board to ensure its work is informed by a variety of stakeholders.

Meeting Recordings

Upcoming Meetings

PDAB Meeting: Friday, June 23 at 10 am MT

PDAAC Meeting & Dashboard Walkthrough: Friday, June 9 at 1 pm MT

Stakeholder Meeting: Wednesday, June 14 at 5:30 pm MT

Questions & Accessibility

Questions about the Prescription Drug Affordability Board and Advisory Council can be sent to dora_ins_pdab@state.co.us.

We are committed to providing equal access to our meetings for all participants. If you would like to request an accommodation to attend a Board or Advisory Council meeting, please contact us at dora_ins_pdab@state.co.us with your request by the close of business at least one week in advance of a meeting.

About PDAB & PDAAC

PDAB

The Prescription Drug Affordability Board (PDAB) is a 5 member Type-1 Board tasked with the following statutory duties:

Identify drugs that may be subject to an affordability review;
Conduct affordability reviews on selected eligible drugs;
Determine whether a prescription drug is unaffordable for Colorado consumers;
If a drug is found to be unaffordable, the Board may set an upper payment limit;
Make policy recommendations to the General Assembly.

PDAB Materials

PDAB Meeting Materials

Rules, Policies, & Written Testimony

Board Members

The Governor appointed the following Prescription Drug Affordability Board Members on September 27, 2021:

Sami Diab, MD of Greenwood Village, Colorado

Amarylis “Amy” Gutierrez, PharmD of Aurora, Colorado

Catherine Harshbarger of Holyoke, Colorado

Gail Mizner, MD, FACP, AAHIVS of Snowmass Village, Colorado and to serve as Board Chair

James Justin VandenBerg, PharmD, BCPS of Denver, Colorado

PDAAC

The Board appointed the 15 member Prescription Drug Affordability Advisory Council (PDAAC) to provide stakeholder input on prescription drug affordability. All PDAAC members meet statutory requirements for composition, geographic representation, and subject matter expertise.

To the extent possible, the Board appointed members who have experience serving underserved communities and who reflect the state’s diversity in terms of race, immigration status, income, disability, age, gender identity, and geography.

PDAAC Materials

PDAAC Meeting Materials

Council Members

Kim Bimestefer Executive Director of HCPF
Gail deVore representing health care consumers
Sarita Parikh representing health care consumers
Edward A. Dauer, LL.B., M.P.H. representing statewide health care advocacy organizations
Kimberley Jackson, DO representing consumers with chronic diseases and PDAAC Chair
Maria Fenwick representing a labor union
Nathan Wilkes representing employers
Chad Friday representing carriers
Marc Reece representing pharmacy benefit managers
Thomas Tobin, MD, MBA representing health care professionals with prescribing authority
R. Brett McQueen, PhD representing an organization that researches prescription drugs
Katelin Lucariello MPH representing manufacturers of brand name drugs
Neal Miller representing manufacturers of generic drugs
Andrew Gonzales, PharmD representing pharmacists
Jason Atlas, RPh, MBA representing wholesalers